Serina Therapeutics, Inc. — Form D
Serina Therapeutics, Inc. of HUNTSVILLE, AL, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-14. The offering totals $3.6M, of which $3.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-11-14
- Form: D
- Accession: 0001558525-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.6M
- Amount sold: $3.6M
- Investors: 1
- Date of first sale: 2022-11-10
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-464772
Issuer
- Name: Serina Therapeutics, Inc.
- CIK: 0001558525
- Entity type: Corporation
- Jurisdiction: ALABAMA
- Address: 601 GENOME WAY, HUNTSVILLE, AL, 35806
- Phone: 2563270566
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Barbara Milton Fisk | Director | Madison, AL |
| Miguel A Loya | Director | Houston, TX |
| Barbara M Fisk | Director | Harvest, AL |
| James R Hudson, Jr. | Director | Huntsville, AL |
| Randall W Moreadith | Director | Huntsville, AL |
| Randall W Moreadith | Executive Officer | Huntsville, AL |
| Steve H Ledger | Director | Mill Valley, CA |
| Greg H Bailey, M.D. | Director | Sliema, O1 |
| J Milton Harris | Director | Huntsville, AL |
| J Milton Harris | Executive Officer | Huntsville, AL |
| Tacey R Viegas | Executive Officer | Madison, AL |
| Michael D Bentley | Director | Huntsville, AL |
| Michael D Bentley | Executive Officer | Huntsville, AL |
| Brendan A Rae | Executive Officer | Huntsville, AL |
| Lonnie S McMillian | Director | Madison, AL |
Other filings by this issuer (15)
More